SI-BONE (SIBN) Financials

$13.65 -0.63 (-4.41%)

As of 04:00 PM Eastern

Annual Income Statements for SI-BONE

This table shows SI-BONE's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	-61	-43	-31
Consolidated Net Income / (Loss)	-61	-43	-31
Net Income / (Loss) Continuing Operations	-61	-43	-31
Total Pre-Tax Income	-61	-43	-31
Total Operating Income	-60	-47	-35
Total Gross Profit	91	109	132
Total Revenue	106	139	167
Operating Revenue	106	139	167
Total Cost of Revenue	16	29	35
Operating Cost of Revenue	16	29	35
Total Operating Expenses	150	156	167
Selling, General & Admin Expense	29	31	34
Marketing Expense	108	110	117
Research & Development Expense	14	15	17
Total Other Income / (Expense), net	-1.52	3.45	4.41
Interest Expense	2.82	3.46	3.44
Interest & Investment Income	1.30	6.92	7.85
Other Gains / (Losses), net	-0.13	0.14	-0.07
Basic Earnings per Share	($1.79)	($1.13)	($0.75)
Weighted Average Basic Shares Outstanding	34.20M	38.43M	41.47M
Diluted Earnings per Share	($1.79)	($1.13)	($0.75)
Weighted Average Diluted Shares Outstanding	34.20M	38.43M	41.47M
Weighted Average Basic & Diluted Shares Outstanding	34.99M	41.06M	42.45M
Cash Dividends to Common per Share	-	$0.00	$0.00

This table shows SI-BONE's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	-14	-11	-11	-11	-10	-11	-11	-8.94	-6.58	-4.50
Consolidated Net Income / (Loss)	-14	-11	-11	-11	-10	-11	-11	-8.94	-6.58	-4.50
Net Income / (Loss) Continuing Operations	-14	-11	-11	-11	-10	-11	-11	-8.94	-6.58	-4.50
Total Pre-Tax Income	-14	-11	-11	-11	-10	-11	-11	-8.94	-6.58	-4.42
Total Operating Income	-14	-11	-11	-12	-11	-13	-12	-10	-7.63	-5.49
Total Gross Profit	22	27	27	27	27	29	30	32	32	39
Total Revenue	26	32	33	33	34	39	38	40	40	49
Operating Revenue	26	32	33	33	34	39	38	40	40	49
Total Cost of Revenue	4.17	5.09	5.92	6.32	7.04	10	8.00	8.39	8.44	10
Operating Cost of Revenue	4.17	5.09	5.92	6.32	7.04	10	8.00	8.39	8.44	10
Total Operating Expenses	36	38	38	39	38	41	42	42	40	44
Selling, General & Admin Expense	7.07	7.07	7.47	7.80	7.71	8.08	8.18	8.33	8.10	9.15
Marketing Expense	26	28	27	27	27	29	29	29	27	31
Research & Development Expense	3.09	3.48	3.29	3.66	3.92	4.16	4.35	4.35	3.99	3.87
Total Other Income / (Expense), net	-0.59	0.25	0.17	0.76	1.15	1.38	1.14	1.14	1.05	1.08
Interest Expense	0.76	0.88	0.84	0.85	0.88	0.89	0.88	0.88	0.88	0.80
Interest & Investment Income	0.35	0.75	0.93	1.58	2.17	2.23	2.11	2.02	1.94	1.78
Basic Earnings per Share	($0.41)	($0.32)	($0.32)	($0.30)	($0.25)	($0.26)	($0.27)	($0.22)	($0.16)	($0.10)
Weighted Average Basic Shares Outstanding	34.36M	34.20M	34.92M	37.86M	40.27M	38.43M	40.93M	41.32M	41.72M	41.47M
Diluted Earnings per Share	($0.41)	($0.32)	($0.32)	($0.30)	($0.25)	($0.26)	($0.27)	($0.22)	($0.16)	($0.10)
Weighted Average Diluted Shares Outstanding	34.36M	34.20M	34.92M	37.86M	40.27M	38.43M	40.93M	41.32M	41.72M	41.47M
Weighted Average Basic & Diluted Shares Outstanding	34.50M	34.99M	35.18M	40.20M	40.50M	41.06M	41.20M	41.69M	41.94M	42.45M

This table details how cash moves in and out of SI-BONE's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Net Change in Cash & Equivalents	-43	13	1.68
Net Cash From Operating Activities	-42	-19	-12
Net Cash From Continuing Operating Activities	-42	-19	-12
Net Income / (Loss) Continuing Operations	-61	-43	-31
Consolidated Net Income / (Loss)	-61	-43	-31
Depreciation Expense	3.45	5.43	4.38
Amortization Expense	0.43	-3.80	-5.29
Non-Cash Adjustments To Reconcile Net Income	24	28	30
Changes in Operating Assets and Liabilities, net	-7.96	-4.83	-10
Net Cash From Investing Activities	-2.82	-60	13
Net Cash From Continuing Investing Activities	-2.82	-60	13
Purchase of Property, Plant & Equipment	-9.51	-7.80	-10
Purchase of Investments	-120	-189	-205
Sale and/or Maturity of Investments	126	138	229
Net Cash From Financing Activities	2.20	91	1.96
Net Cash From Continuing Financing Activities	2.20	91	1.96
Repayment of Debt	0.00	-35	-36
Issuance of Debt	0.00	36	36
Issuance of Common Equity	1.82	86	2.15
Other Financing Activities, net	0.38	4.39	-0.15
Effect of Exchange Rate Changes	-0.43	0.13	-0.48
Cash Interest Paid	2.62	3.26	3.35

This table details how cash moves in and out of SI-BONE's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	1.98	-5.58	2.25	88	-57	-20	-1.23	-6.46	4.65	4.72
Net Cash From Operating Activities	-6.53	-6.78	-11	-3.59	-2.07	-2.30	-7.57	-6.33	0.30	1.18
Net Cash From Continuing Operating Activities	-6.53	-6.78	-11	-3.59	-2.07	-2.30	-7.57	-6.33	0.30	1.18
Net Income / (Loss) Continuing Operations	-14	-11	-11	-11	-10	-11	-11	-8.94	-6.58	-4.50
Consolidated Net Income / (Loss)	-14	-11	-11	-11	-10	-11	-11	-8.94	-6.58	-4.50
Depreciation Expense	0.95	1.00	1.09	1.24	1.53	1.57	1.09	0.99	1.09	1.21
Amortization Expense	0.16	-0.35	-0.53	-0.59	-1.13	-1.55	-1.52	-1.42	-1.19	-1.16
Non-Cash Adjustments To Reconcile Net Income	6.00	6.32	6.43	6.36	6.81	8.23	7.50	7.35	7.08	7.59
Changes in Operating Assets and Liabilities, net	0.53	-2.57	-6.61	0.61	0.73	0.44	-3.74	-4.33	-0.09	-1.97
Net Cash From Investing Activities	8.73	0.09	12	2.28	-55	-19	6.35	-1.83	3.77	4.34
Net Cash From Continuing Investing Activities	8.73	0.09	12	2.28	-55	-19	6.35	-1.83	3.77	4.34
Purchase of Property, Plant & Equipment	-3.57	-1.66	-2.58	-2.71	-1.41	-1.09	-2.08	-3.11	-3.04	-2.27
Purchase of Investments	-30	-34	-16	-34	-78	-62	-59	-51	-61	-35
Sale and/or Maturity of Investments	42	36	30	39	25	44	67	52	68	42
Net Cash From Financing Activities	0.11	0.69	1.21	89	-0.24	0.84	0.11	1.78	0.16	-0.08
Net Cash From Continuing Financing Activities	0.11	0.69	1.21	89	-0.24	0.84	0.11	1.78	0.16	-0.08
Repayment of Debt	-	-	-35	-	-	-	0.00	-	-	-36
Issuance of Debt	-	-	36	-	-	-	0.00	-	-	36
Issuance of Common Equity	-	0.62	-	-	-0.47	0.72	-	-	-	0.68
Other Financing Activities, net	0.11	0.07	0.52	3.52	0.23	0.12	0.11	0.30	0.16	-0.71
Effect of Exchange Rate Changes	-0.33	0.41	0.10	0.03	-0.14	0.15	-0.11	-0.08	0.42	-0.71

This table presents SI-BONE's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Total Assets	158	230	230
Total Current Assets	138	211	208
Cash & Equivalents	21	33	35
Short-Term Investments	77	133	115
Accounts Receivable	21	22	27
Inventories, net	17	20	27
Prepaid Expenses	2.37	3.17	3.20
Plant, Property, & Equipment, net	16	16	20
Total Noncurrent Assets	4.38	3.03	2.28
Other Noncurrent Operating Assets	4.38	3.03	2.28
Total Liabilities & Shareholders' Equity	158	230	230
Total Liabilities	59	61	63
Total Current Liabilities	21	23	27
Accounts Payable	6.28	4.59	6.49
Accrued Expenses	14	17	19
Other Current Liabilities	1.39	1.42	1.15
Total Noncurrent Liabilities	38	38	36
Long-Term Debt	35	36	35
Capital Lease Obligations	2.87	1.51	0.88
Other Noncurrent Operating Liabilities	0.03	0.02	0.01
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	98	169	167
Total Preferred & Common Equity	98	169	167
Preferred Stock	0.00	0.00	0.00
Total Common Equity	98	169	167
Common Stock	455	569	598
Retained Earnings	-357	-400	-431
Accumulated Other Comprehensive Income / (Loss)	0.23	0.34	0.24

This table presents SI-BONE's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	158	149	234	231	224	224	227
Total Current Assets	139	128	213	211	204	202	204
Cash & Equivalents	26	23	111	53	32	26	30
Short-Term Investments	78	63	59	113	126	126	121
Accounts Receivable	16	23	20	20	22	25	25
Inventories, net	17	18	21	22	21	23	26
Prepaid Expenses	1.79	2.05	2.14	1.94	2.65	2.78	2.45
Plant, Property, & Equipment, net	14	17	18	16	17	19	21
Total Noncurrent Assets	4.64	4.05	3.71	3.37	2.74	2.40	2.55
Other Noncurrent Operating Assets	4.64	4.05	3.71	3.37	2.74	2.40	2.55
Total Liabilities & Shareholders' Equity	158	149	234	231	224	224	227
Total Liabilities	55	55	56	57	58	59	62
Total Current Liabilities	19	17	18	19	21	22	25
Accounts Payable	4.61	5.33	6.16	4.42	7.66	7.18	7.32
Accrued Expenses	11	9.90	11	14	12	13	16
Other Current Liabilities	1.34	1.40	1.40	1.40	1.43	1.38	1.21
Total Noncurrent Liabilities	37	38	38	38	37	37	37
Long-Term Debt	34	36	36	36	36	36	36
Capital Lease Obligations	3.18	2.53	2.21	1.87	1.19	0.89	1.14
Other Noncurrent Operating Liabilities	0.03	0.03	0.02	0.02	0.02	0.01	0.01
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	103	94	177	174	166	165	165
Total Preferred & Common Equity	103	94	177	174	166	165	165
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	103	94	177	174	166	165	165
Common Stock	449	462	557	563	577	585	591
Retained Earnings	-346	-368	-379	-389	-411	-420	-427
Accumulated Other Comprehensive Income / (Loss)	0.16	0.30	0.30	0.36	0.27	0.23	0.58

This table displays calculated financial ratios and metrics derived from SI-BONE's official financial filings.

Metric	2022	2023	2024
Growth Metrics	-	-	-
Revenue Growth	18.03%	30.52%	20.37%
EBITDA Growth	-16.77%	18.71%	20.19%
EBIT Growth	-15.99%	21.27%	24.89%
NOPAT Growth	-15.36%	21.27%	24.89%
Net Income Growth	-8.28%	29.25%	28.67%
EPS Growth	-4.68%	36.87%	33.63%
Operating Cash Flow Growth	-5.37%	55.08%	33.60%
Free Cash Flow Firm Growth	-7.62%	35.92%	-6.52%
Invested Capital Growth	46.93%	4.81%	30.10%
Revenue Q/Q Growth	6.74%	5.23%	6.46%
EBITDA Q/Q Growth	4.69%	-4.73%	16.30%
EBIT Q/Q Growth	4.84%	-3.12%	16.59%
NOPAT Q/Q Growth	4.24%	-2.65%	16.59%
Net Income Q/Q Growth	5.11%	0.44%	17.35%
EPS Q/Q Growth	6.28%	5.04%	17.58%
Operating Cash Flow Q/Q Growth	12.48%	19.31%	21.86%
Free Cash Flow Firm Q/Q Growth	13.87%	12.50%	-1.83%
Invested Capital Q/Q Growth	5.43%	-8.50%	3.44%
Profitability Metrics	-	-	-
Gross Margin	85.24%	78.78%	79.03%
EBITDA Margin	-52.37%	-32.62%	-21.63%
Operating Margin	-56.02%	-33.79%	-21.08%
EBIT Margin	-56.02%	-33.79%	-21.08%
Profit (Net Income) Margin	-57.57%	-31.20%	-18.49%
Tax Burden Percent	100.22%	99.68%	100.24%
Interest Burden Percent	102.54%	92.64%	87.49%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-127.15%	-82.14%	-52.39%
ROIC Less NNEP Spread (ROIC-NNEP)	-103.77%	-70.97%	-47.24%
Return on Net Nonoperating Assets (RNNOA)	74.51%	49.76%	34.01%
Return on Equity (ROE)	-52.64%	-32.38%	-18.38%
Cash Return on Invested Capital (CROIC)	-165.16%	-86.84%	-78.56%
Operating Return on Assets (OROA)	-34.25%	-24.19%	-15.30%
Return on Assets (ROA)	-35.20%	-22.34%	-13.42%
Return on Common Equity (ROCE)	-52.64%	-32.38%	-18.38%
Return on Equity Simple (ROE_SIMPLE)	-62.31%	-25.59%	-18.51%
Net Operating Profit after Tax (NOPAT)	-42	-33	-25
NOPAT Margin	-39.21%	-23.65%	-14.76%
Net Nonoperating Expense Percent (NNEP)	-23.38%	-11.17%	-5.15%
Return On Investment Capital (ROIC_SIMPLE)	-30.60%	-15.87%	-12.14%
Cost of Revenue to Revenue	14.76%	21.22%	20.97%
SG&A Expenses to Revenue	27.22%	22.37%	20.19%
R&D to Revenue	12.81%	10.82%	9.91%
Operating Expenses to Revenue	141.26%	112.58%	100.11%
Earnings before Interest and Taxes (EBIT)	-60	-47	-35
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-56	-45	-36
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	4.77	5.02	3.52
Price to Tangible Book Value (P/TBV)	4.77	5.02	3.52
Price to Revenue (P/Rev)	4.41	6.12	3.52
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	10.50	17.63	8.91
Enterprise Value to Revenue (EV/Rev)	3.85	5.20	2.84
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.39	0.22	0.22
Long-Term Debt to Equity	0.39	0.22	0.22
Financial Leverage	-0.72	-0.70	-0.72
Leverage Ratio	1.50	1.45	1.37
Compound Leverage Factor	1.53	1.34	1.20
Debt to Total Capital	27.90%	18.16%	17.87%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	27.90%	18.16%	17.87%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	72.10%	81.84%	82.13%
Debt to EBITDA	-0.68	-0.83	-1.00
Net Debt to EBITDA	1.06	2.84	3.15
Long-Term Debt to EBITDA	-0.68	-0.83	-1.00
Debt to NOPAT	-0.91	-1.14	-1.47
Net Debt to NOPAT	1.42	3.91	4.61
Long-Term Debt to NOPAT	-0.91	-1.14	-1.47
Altman Z-Score	1.89	6.83	4.10
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	6.50	9.01	7.66
Quick Ratio	5.57	8.01	6.54
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-54	-35	-37
Operating Cash Flow to CapEx	-438.15%	-239.94%	-118.37%
Free Cash Flow to Firm to Interest Expense	-19.23	-10.03	-10.75
Operating Cash Flow to Interest Expense	-14.78	-5.41	-3.61
Operating Cash Flow Less CapEx to Interest Expense	-18.15	-7.66	-6.66
Efficiency Ratios	-	-	-
Asset Turnover	0.61	0.72	0.73
Accounts Receivable Turnover	6.09	6.52	6.77
Inventory Turnover	1.09	1.57	1.48
Fixed Asset Turnover	8.67	8.80	9.19
Accounts Payable Turnover	3.31	5.42	6.33
Days Sales Outstanding (DSO)	59.89	56.01	53.94
Days Inventory Outstanding (DIO)	334.44	232.45	246.35
Days Payable Outstanding (DPO)	110.13	67.31	57.66
Cash Conversion Cycle (CCC)	284.20	221.16	242.64
Capital & Investment Metrics	-	-	-
Invested Capital	39	41	53
Invested Capital Turnover	3.24	3.47	3.55
Increase / (Decrease) in Invested Capital	12	1.88	12
Enterprise Value (EV)	410	722	474
Market Capitalization	469	850	588
Book Value per Share	$2.85	$4.18	$3.98
Tangible Book Value per Share	$2.85	$4.18	$3.98
Total Capital	136	207	203
Total Debt	38	38	36
Total Long-Term Debt	38	38	36
Net Debt	-59	-128	-114
Capital Expenditures (CapEx)	9.51	7.80	10
Debt-free, Cash-free Net Working Capital (DFCFNWC)	19	22	31
Debt-free Net Working Capital (DFNWC)	116	188	181
Net Working Capital (NWC)	116	188	181
Net Nonoperating Expense (NNE)	20	10	6.24
Net Nonoperating Obligations (NNO)	-59	-128	-114
Total Depreciation and Amortization (D&A)	3.88	1.63	-0.91
Debt-free, Cash-free Net Working Capital to Revenue	17.99%	15.78%	18.31%
Debt-free Net Working Capital to Revenue	109.42%	135.32%	108.06%
Net Working Capital to Revenue	109.42%	135.32%	108.06%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($1.79)	($1.13)	($0.75)
Adjusted Weighted Average Basic Shares Outstanding	34.20M	38.43M	41.47M
Adjusted Diluted Earnings per Share	($1.79)	($1.13)	($0.75)
Adjusted Weighted Average Diluted Shares Outstanding	34.20M	38.43M	41.47M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	34.99M	41.06M	42.45M
Normalized Net Operating Profit after Tax (NOPAT)	-42	-33	-25
Normalized NOPAT Margin	-39.21%	-23.65%	-14.76%
Pre Tax Income Margin	-57.44%	-31.30%	-18.45%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	-21.15	-13.56	-10.25
NOPAT to Interest Expense	-14.80	-9.49	-7.17
EBIT Less CapEx to Interest Expense	-24.52	-15.81	-13.30
NOPAT Less CapEx to Interest Expense	-18.17	-11.74	-10.22
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from SI-BONE's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	18.60%	26.65%	45.76%	30.17%	28.68%	21.61%	15.77%	20.01%	18.60%	26.10%
EBITDA Growth	-3.01%	18.15%	32.97%	33.23%	13.75%	-17.29%	-17.80%	7.06%	29.01%	56.41%
EBIT Growth	-3.70%	19.00%	33.70%	33.78%	17.72%	-10.73%	-8.17%	15.61%	32.52%	56.07%
NOPAT Growth	-2.78%	18.93%	33.05%	33.10%	17.67%	-10.73%	-6.64%	15.76%	31.66%	56.07%
Net Income Growth	10.80%	22.81%	36.10%	39.47%	29.21%	1.72%	1.99%	20.23%	34.39%	59.07%
EPS Growth	14.58%	27.27%	38.46%	44.44%	39.02%	18.75%	15.63%	26.67%	36.00%	61.54%
Operating Cash Flow Growth	29.89%	46.71%	20.42%	75.81%	68.24%	66.10%	29.59%	-76.43%	114.57%	151.28%
Free Cash Flow Firm Growth	-64.40%	14.89%	9.62%	35.67%	46.25%	47.83%	70.57%	42.99%	22.03%	-52.06%
Invested Capital Growth	109.42%	46.93%	51.72%	31.82%	20.76%	4.81%	-3.10%	8.82%	15.09%	30.10%
Revenue Q/Q Growth	3.31%	20.89%	2.36%	1.83%	2.13%	14.24%	-2.55%	5.55%	0.93%	21.47%
EBITDA Q/Q Growth	25.25%	15.83%	-2.66%	-5.88%	3.44%	-14.46%	-2.19%	16.47%	26.26%	29.71%
EBIT Q/Q Growth	23.73%	17.86%	-1.59%	-6.41%	5.24%	-10.56%	1.50%	16.99%	24.23%	28.02%
NOPAT Q/Q Growth	24.13%	16.75%	0.01%	-5.93%	6.64%	-11.97%	3.70%	16.32%	24.26%	28.02%
Net Income Q/Q Growth	23.52%	21.07%	0.45%	-0.73%	10.57%	-9.59%	0.72%	18.02%	26.45%	31.64%
EPS Q/Q Growth	24.07%	21.95%	0.00%	6.25%	16.67%	-4.00%	-3.85%	18.52%	27.27%	37.50%
Operating Cash Flow Q/Q Growth	56.02%	-3.80%	-58.72%	66.61%	42.26%	-10.81%	-229.60%	16.34%	104.77%	290.07%
Free Cash Flow Firm Q/Q Growth	4.92%	29.36%	-16.49%	17.78%	20.55%	31.44%	34.27%	-59.24%	-8.67%	-33.70%
Invested Capital Q/Q Growth	5.77%	5.43%	18.95%	-0.62%	-3.11%	-8.50%	9.97%	11.61%	2.47%	3.44%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	84.23%	84.07%	81.89%	81.03%	79.30%	73.80%	78.87%	79.00%	79.09%	79.13%
EBITDA Margin	-47.83%	-33.31%	-32.61%	-33.91%	-32.06%	-32.12%	-33.18%	-26.26%	-19.19%	-11.10%
Operating Margin	-51.32%	-35.35%	-34.53%	-35.92%	-32.84%	-32.18%	-31.80%	-25.21%	-18.92%	-11.21%
EBIT Margin	-52.02%	-35.35%	-34.30%	-35.84%	-33.26%	-32.18%	-32.05%	-25.20%	-18.92%	-11.21%
Profit (Net Income) Margin	-53.56%	-34.97%	-34.01%	-33.65%	-29.46%	-28.26%	-28.80%	-22.36%	-16.30%	-9.17%
Tax Burden Percent	100.00%	101.20%	100.00%	100.00%	100.00%	98.73%	100.00%	100.00%	99.91%	101.79%
Interest Burden Percent	102.97%	97.78%	99.16%	93.87%	88.60%	88.95%	89.85%	88.73%	86.22%	80.38%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-130.87%	-80.23%	-73.17%	-77.05%	-74.19%	-78.23%	-70.12%	-55.18%	-43.23%	-27.86%
ROIC Less NNEP Spread (ROIC-NNEP)	-126.01%	-76.31%	-68.55%	-74.31%	-71.93%	-75.86%	-67.17%	-53.65%	-42.22%	-27.33%
Return on Net Nonoperating Assets (RNNOA)	98.02%	54.79%	44.13%	53.38%	50.65%	53.19%	43.49%	38.53%	30.22%	19.67%
Return on Equity (ROE)	-32.85%	-25.44%	-29.04%	-23.67%	-23.54%	-25.04%	-26.62%	-16.65%	-13.01%	-8.19%
Cash Return on Invested Capital (CROIC)	-229.94%	-165.16%	-139.24%	-110.42%	-97.08%	-86.84%	-69.83%	-74.95%	-75.52%	-78.56%
Operating Return on Assets (OROA)	-29.44%	-21.61%	-24.56%	-22.30%	-22.56%	-23.04%	-24.77%	-16.60%	-12.98%	-8.13%
Return on Assets (ROA)	-30.32%	-21.38%	-24.35%	-20.93%	-19.99%	-20.24%	-22.25%	-14.73%	-11.18%	-6.66%
Return on Common Equity (ROCE)	-32.85%	-25.44%	-29.04%	-23.67%	-23.54%	-25.04%	-26.62%	-16.65%	-13.01%	-8.19%
Return on Equity Simple (ROE_SIMPLE)	-62.78%	0.00%	-58.51%	-26.87%	-25.07%	0.00%	-26.05%	-24.80%	-22.67%	0.00%
Net Operating Profit after Tax (NOPAT)	-9.50	-7.91	-7.91	-8.37	-7.82	-8.75	-8.43	-7.05	-5.34	-3.85
NOPAT Margin	-35.93%	-24.74%	-24.17%	-25.14%	-22.99%	-22.53%	-22.26%	-17.65%	-13.25%	-7.85%
Net Nonoperating Expense Percent (NNEP)	-4.86%	-3.91%	-4.62%	-2.74%	-2.26%	-2.38%	-2.94%	-1.53%	-1.02%	-0.54%
Return On Investment Capital (ROIC_SIMPLE)	-	-5.80%	-	-	-	-4.23%	-	-	-	-1.89%
Cost of Revenue to Revenue	15.77%	15.93%	18.11%	18.97%	20.70%	26.21%	21.13%	21.00%	20.91%	20.87%
SG&A Expenses to Revenue	26.76%	22.12%	22.85%	23.43%	22.67%	20.80%	21.59%	20.85%	20.07%	18.68%
R&D to Revenue	11.69%	10.89%	10.06%	10.98%	11.52%	10.71%	11.47%	10.89%	9.90%	7.90%
Operating Expenses to Revenue	135.56%	119.42%	116.41%	116.95%	112.14%	105.98%	110.67%	104.22%	98.01%	90.35%
Earnings before Interest and Taxes (EBIT)	-14	-11	-11	-12	-11	-13	-12	-10	-7.63	-5.49
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-13	-11	-11	-11	-11	-12	-13	-10	-7.74	-5.44
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	5.82	4.77	7.32	5.35	4.92	5.02	4.01	3.23	3.53	3.52
Price to Tangible Book Value (P/TBV)	5.82	4.77	7.32	5.35	4.92	5.02	4.01	3.23	3.53	3.52
Price to Revenue (P/Rev)	6.01	4.41	5.90	7.63	6.47	6.12	4.60	3.54	3.71	3.52
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	14.39	10.50	13.79	17.72	16.21	17.63	12.05	8.33	9.12	8.91
Enterprise Value to Revenue (EV/Rev)	5.35	3.85	5.49	6.58	5.49	5.20	3.77	2.78	2.99	2.84
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.37	0.39	0.41	0.22	0.22	0.22	0.23	0.22	0.23	0.22
Long-Term Debt to Equity	0.36	0.39	0.41	0.22	0.22	0.22	0.23	0.22	0.23	0.22
Financial Leverage	-0.78	-0.72	-0.64	-0.72	-0.70	-0.70	-0.65	-0.72	-0.72	-0.72
Leverage Ratio	1.43	1.50	1.51	1.39	1.41	1.45	1.44	1.34	1.35	1.37
Compound Leverage Factor	1.47	1.46	1.49	1.30	1.25	1.29	1.29	1.19	1.17	1.10
Debt to Total Capital	27.14%	27.90%	29.05%	17.71%	17.91%	18.16%	18.39%	18.36%	18.45%	17.87%
Short-Term Debt to Total Capital	1.03%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	26.11%	27.90%	29.05%	17.71%	17.91%	18.16%	18.39%	18.36%	18.45%	17.87%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	72.86%	72.10%	70.95%	82.29%	82.09%	81.84%	81.61%	81.64%	81.55%	82.13%
Debt to EBITDA	-0.66	-0.68	-0.76	-0.85	-0.88	-0.83	-0.79	-0.80	-0.86	-1.00
Net Debt to EBITDA	1.13	1.06	0.94	2.92	2.98	2.84	2.56	2.47	2.63	3.15
Long-Term Debt to EBITDA	-0.63	-0.68	-0.76	-0.85	-0.88	-0.83	-0.79	-0.80	-0.86	-1.00
Debt to NOPAT	-0.88	-0.91	-1.02	-1.13	-1.18	-1.14	-1.12	-1.16	-1.26	-1.47
Net Debt to NOPAT	1.51	1.42	1.26	3.90	4.03	3.91	3.61	3.57	3.84	4.61
Long-Term Debt to NOPAT	-0.85	-0.91	-1.02	-1.13	-1.18	-1.14	-1.12	-1.16	-1.26	-1.47
Altman Z-Score	4.68	2.90	5.47	9.18	7.99	7.32	5.71	4.27	4.53	4.52
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	7.50	6.50	7.72	11.68	10.89	9.01	9.76	9.17	8.25	7.66
Quick Ratio	6.49	5.57	6.53	10.43	9.64	8.01	8.63	7.99	7.12	6.54
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-29	-20	-24	-20	-16	-11	-6.99	-11	-12	-16
Operating Cash Flow to CapEx	-182.73%	-408.13%	-416.94%	-132.28%	-146.71%	-210.16%	-363.64%	-203.47%	9.95%	51.99%
Free Cash Flow to Firm to Interest Expense	-38.21	-23.13	-28.33	-22.96	-17.54	-11.95	-7.93	-12.65	-13.68	-20.34
Operating Cash Flow to Interest Expense	-8.65	-7.69	-12.83	-4.22	-2.35	-2.58	-8.59	-7.20	0.34	1.48
Operating Cash Flow Less CapEx to Interest Expense	-13.38	-9.57	-15.91	-7.42	-3.94	-3.81	-10.96	-10.74	-3.09	-1.37
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.57	0.61	0.72	0.62	0.68	0.72	0.77	0.66	0.69	0.73
Accounts Receivable Turnover	6.86	6.09	6.61	7.00	7.24	6.52	6.44	6.67	7.00	6.77
Inventory Turnover	1.03	1.09	1.15	1.16	1.24	1.57	1.62	1.54	1.46	1.48
Fixed Asset Turnover	8.92	8.67	8.67	8.19	8.53	8.80	8.48	8.22	8.43	9.19
Accounts Payable Turnover	3.20	3.31	3.61	3.81	5.40	5.42	4.86	5.04	5.97	6.33
Days Sales Outstanding (DSO)	53.22	59.89	55.19	52.14	50.39	56.01	56.64	54.76	52.18	53.94
Days Inventory Outstanding (DIO)	353.47	334.44	318.05	314.35	293.44	232.45	224.71	237.66	249.41	246.35
Days Payable Outstanding (DPO)	114.16	110.13	101.10	95.91	67.64	67.31	75.17	72.40	61.18	57.66
Cash Conversion Cycle (CCC)	292.53	284.20	272.14	270.58	276.19	221.16	206.18	220.02	240.41	242.64
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	37	39	46	46	45	41	45	50	51	53
Invested Capital Turnover	3.64	3.24	3.03	3.06	3.23	3.47	3.15	3.13	3.26	3.55
Increase / (Decrease) in Invested Capital	19	12	16	11	7.69	1.88	-1.44	4.07	6.75	12
Enterprise Value (EV)	533	410	641	818	725	722	542	418	469	474
Market Capitalization	599	469	688	949	854	850	663	533	583	588
Book Value per Share	$3.00	$2.85	$2.69	$5.04	$4.32	$4.18	$4.04	$4.00	$3.96	$3.98
Tangible Book Value per Share	$3.00	$2.85	$2.69	$5.04	$4.32	$4.18	$4.04	$4.00	$3.96	$3.98
Total Capital	141	136	132	216	211	207	203	202	202	203
Total Debt	38	38	38	38	38	38	37	37	37	36
Total Long-Term Debt	37	38	38	38	38	38	37	37	37	36
Net Debt	-66	-59	-48	-131	-129	-128	-121	-114	-113	-114
Capital Expenditures (CapEx)	3.57	1.66	2.58	2.71	1.41	1.09	2.08	3.11	3.04	2.27
Debt-free, Cash-free Net Working Capital (DFCFNWC)	18	19	26	25	25	22	25	29	28	31
Debt-free Net Working Capital (DFNWC)	122	116	112	194	192	188	183	180	179	181
Net Working Capital (NWC)	121	116	112	194	192	188	183	180	179	181
Net Nonoperating Expense (NNE)	4.66	3.27	3.22	2.83	2.20	2.23	2.47	1.88	1.23	0.65
Net Nonoperating Obligations (NNO)	-66	-59	-48	-131	-129	-128	-121	-114	-113	-114
Total Depreciation and Amortization (D&A)	1.11	0.65	0.55	0.64	0.41	0.02	-0.43	-0.42	-0.11	0.05
Debt-free, Cash-free Net Working Capital to Revenue	18.05%	17.99%	22.12%	20.02%	18.86%	15.78%	17.32%	19.07%	17.96%	18.31%
Debt-free Net Working Capital to Revenue	122.46%	109.42%	95.80%	156.22%	145.21%	135.32%	126.88%	119.62%	114.00%	108.06%
Net Working Capital to Revenue	121.00%	109.42%	95.80%	156.22%	145.21%	135.32%	126.88%	119.62%	114.00%	108.06%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.41)	($0.32)	($0.32)	($0.30)	($0.25)	($0.26)	($0.27)	($0.22)	($0.16)	($0.10)
Adjusted Weighted Average Basic Shares Outstanding	34.36M	34.20M	34.92M	37.86M	40.27M	38.43M	40.93M	41.32M	41.72M	41.47M
Adjusted Diluted Earnings per Share	($0.41)	($0.32)	($0.32)	($0.30)	($0.25)	($0.26)	($0.27)	($0.22)	($0.16)	($0.10)
Adjusted Weighted Average Diluted Shares Outstanding	34.36M	34.20M	34.92M	37.86M	40.27M	38.43M	40.93M	41.32M	41.72M	41.47M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	34.50M	34.99M	35.18M	40.20M	40.50M	41.06M	41.20M	41.69M	41.94M	42.45M
Normalized Net Operating Profit after Tax (NOPAT)	-9.50	-7.91	-7.91	-8.37	-7.82	-8.75	-8.43	-7.05	-5.34	-3.85
Normalized NOPAT Margin	-35.93%	-24.74%	-24.17%	-25.14%	-22.99%	-22.53%	-22.26%	-17.65%	-13.25%	-7.85%
Pre Tax Income Margin	-53.56%	-34.56%	-34.01%	-33.65%	-29.46%	-28.63%	-28.80%	-22.36%	-16.31%	-9.01%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-18.21	-12.82	-13.39	-14.04	-12.80	-14.05	-13.78	-11.45	-8.63	-6.91
NOPAT to Interest Expense	-12.58	-8.97	-9.43	-9.85	-8.84	-9.84	-9.57	-8.02	-6.04	-4.84
EBIT Less CapEx to Interest Expense	-22.94	-14.70	-16.47	-17.24	-14.39	-15.28	-16.14	-14.99	-12.07	-9.76
NOPAT Less CapEx to Interest Expense	-17.31	-10.86	-12.51	-13.04	-10.44	-11.06	-11.93	-11.55	-9.48	-7.69
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About SI-BONE's Financials

When does SI-BONE's financial year end?

According to the most recent income statement we have on file, SI-BONE's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has SI-BONE's net income changed over the last 2 years?

SI-BONE's net income appears to be on a downward trend, with a most recent value of -$30.91 million in 2024, falling from -$61.26 million in 2022. The previous period was -$43.34 million in 2023.

What is SI-BONE's operating income?

SI-BONE's total operating income in 2024 was -$35.25 million, based on the following breakdown:

Total Gross Profit: $132.12 million
Total Operating Expenses: $167.37 million

How has SI-BONE revenue changed over the last 2 years?

Over the last 2 years, SI-BONE's total revenue changed from $106.41 million in 2022 to $167.18 million in 2024, a change of 57.1%.

How much debt does SI-BONE have?

SI-BONE's total liabilities were at $63.47 million at the end of 2024, a 4.0% increase from 2023, and a 7.1% increase since 2022.

How much cash does SI-BONE have?

In the past 2 years, SI-BONE's cash and equivalents has ranged from $20.72 million in 2022 to $34.95 million in 2024, and is currently $34.95 million as of their latest financial filing in 2024.

How has SI-BONE's book value per share changed over the last 2 years?

Over the last 2 years, SI-BONE's book value per share changed from 2.85 in 2022 to 3.98 in 2024, a change of 39.7%.

Related Companies

This page (NASDAQ:SIBN) was last updated on 4/30/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SI-BONE (SIBN) Financials

Frequently Asked Questions About SI-BONE's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

SI-BONE (SIBN) Financials

Annual Income Statements for SI-BONE

Quarterly Income Statements for SI-BONE

Annual Cash Flow Statements for SI-BONE

Quarterly Cash Flow Statements for SI-BONE

Annual Balance Sheets for SI-BONE

Quarterly Balance Sheets for SI-BONE

Annual Metrics and Ratios for SI-BONE

Quarterly Metrics and Ratios for SI-BONE

Frequently Asked Questions About SI-BONE's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools